|
METTL13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62569999995199E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.15130000000185E-06 |
| Normal-vs-Stage2 |
6.838100E-04 |
| Normal-vs-Stage3 |
2.188900E-04 |
| Normal-vs-Stage4 |
2.814200E-04 |
| Stage1-vs-Stage2 |
8.079400E-01 |
| Stage1-vs-Stage3 |
3.921000E-01 |
| Stage1-vs-Stage4 |
9.519000E-01 |
| Stage2-vs-Stage3 |
7.333400E-01 |
| Stage2-vs-Stage4 |
8.254400E-01 |
| Stage3-vs-Stage4 |
5.376800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.38960000004318E-06 |
| Normal-vs-AfricanAmerican |
8.430500E-02 |
| Normal-vs-Asian |
3.795700E-04 |
| Caucasian-vs-AfricanAmerican |
1.436020E-01 |
| Caucasian-vs-Asian |
9.503400E-01 |
| AfricanAmerican-vs-Asian |
1.839360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.2584999998253E-07 |
| Normal-vs-Female |
2.02269999999283E-05 |
| Male-vs-Female |
7.924200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.87380000005177E-06 |
| Normal-vs-Age(41-60Yrs) |
6.45470000000259E-05 |
| Normal-vs-Age(61-80Yrs) |
4.15670000000201E-05 |
| Normal-vs-Age(81-100Yrs) |
2.128000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.516000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.658200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.452200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.407200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.176600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.634200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.943780E-01 |
| Classical-VS-Follicular |
9.68669999990013E-07 |
| Classical-VS-Other |
5.367800E-02 |
| Classical-VS-Normal |
3.815600E-04 |
| Tall-VS-Follicular |
5.961900E-02 |
| Tall-VS-Other |
1.981210E-01 |
| Tall-VS-Normal |
1.350210E-04 |
| Follicular-VS-Other |
7.823400E-01 |
| Follicular-VS-Normal |
1.26569998926129E-09 |
| Other-VS-Normal |
8.608500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.59699999955099E-07 |
| Normal-vs-N1 |
1.08800000009346E-07 |
| N0-vs-N1 |
4.446100E-02 |
|
|
